This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

stereotactic ablative radiotherapy (SABR)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Stereotactic radiotherapy (SBRT) gives radiotherapy from many different positions around the body
    • the beams meet at the tumour
      • the tumour receives a high dose of radiation and the tissues around it only receive a low dose
    • also termed stereotactic ablative radiotherapy (SABR)
      • characterized by high doses of radiation per fraction (5-34 Gy), few overall treatment fractions and an accurate tumour targeting system
        • doses delivered in SABR are in contrast to those given in conventionally fractionated radiotherapy, which are typically in the range of 1.8-2 Gy per fraction daily, delivered over several weeks
        • SABR has become widely available due to the advancement of technology in both imaging target tumours and in the precise delivery of radiation

    • lowers the risk of side effects
    • usually you have between 1 to 8 treatments
      • SBRT may be used to treat brain tumours and is called cranial stereotactic radiotherapy

    • this type of radiotherapy is mainly used to treat very small cancers, including:
      • lung cancer
      • liver cancer or liver metastases
      • cancers in the lymph nodes
      • spinal cord tumours

Reference:

  • Lax I, Blomgren H, Näslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-83
  • Bezjak A. RTOG 0813: Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically In-operable Patients.
  • Meyer J, Wilbert J, Baier K, et al. Positioning accuracy of conebeam computed tomography in combination with a HexaPOD robot treatment table. Int J Radiat Oncol Biol Phys 2007;67:1220-8.
  • Li Q, Mu J, Gu W, et al. Frameless stereotactic body radiation therapy for multiple lung metastases. J Appl Clin Med Phys 2014;15:4737.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page